SHOCK, CARDIOGENIC
Clinical trials for SHOCK, CARDIOGENIC explained in plain language.
Never miss a new study
Get alerted when new SHOCK, CARDIOGENIC trials appear
Sign up with your email to follow new studies for SHOCK, CARDIOGENIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New antibody could help hearts in crisis
Disease control Recruiting nowThis study tests a new drug called procizumab for people with cardiogenic shock, a life-threatening condition where the heart can't pump enough blood. The drug is an antibody that targets a protein called DPP3, which is often high in these patients. The trial will check if the dr…
Matched conditions: SHOCK, CARDIOGENIC
Phase: PHASE1, PHASE2 • Sponsor: 4TEEN4 Pharmaceuticals GmbH • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
Heart pump drugs under scrutiny: do they really help in shock?
Symptom relief Recruiting nowThis study looks at whether drugs that help the heart pump stronger (inotropes) actually help people in cardiogenic shock, a life-threatening condition where the heart can't pump enough blood. About 346 critically ill adults will get either one of two common drugs (milrinone or d…
Matched conditions: SHOCK, CARDIOGENIC
Phase: PHASE4 • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Symptom relief
Last updated May 26, 2026 05:41 UTC